Botulinum toxin for the treatment of hypercontractile esophagus: Results of a double-blind randomized sham-controlled study.

Mion, François; Marjoux, Sophie; Subtil, Fabien; Pioche, Mathieu; Rivory, Jerome; Roman, Sabine; Zerbib, Frank

Mion, François; Marjoux, Sophie; Subtil, Fabien; Pioche, Mathieu; Rivory, Jerome; Roman, Sabine; Zerbib, Frank.

Affiliation

Mion F; Hospices Civils de Lyon, Hospital E. Herriot, Digestive Physiology, Lyon, France.
Marjoux S; Physiology Department, Université de Lyon, Lyon, France.
Subtil F; LabTau, INSERM U1032, Lyon, France.
Pioche M; Hospices Civils de Lyon, Hospital E. Herriot, Digestive Physiology, Lyon, France.
Rivory J; Biostatistics Department, Hospices Civils de Lyon, Hospital E. Herriot, Lyon, France.
Roman S; Gastroenterology, Hospices Civils de Lyon, Hospital E. Herriot, Lyon, France.
Zerbib F; Gastroenterology, Hospices Civils de Lyon, Hospital E. Herriot, Lyon, France.

Neurogastroenterol Motil ; 31(5): e13587, 2019 05.

Article in En | MEDLINE | ID: mdl-30974039

Subject(s)
Key words

achalasia; dysphagia; esophageal high-resolution manometry; esophageal motility disorders; thoracic pain

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Motility Disorders / Botulinum Toxins, Type A / Neuromuscular Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neurogastroenterol Motil Journal subject: GASTROENTEROLOGIA / NEUROLOGIA Year: 2019 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google